Legal Planning After a Dementia Diagnosis: 3 Things You Need To Know
People living with dementia face complex legal concerns, and the actions that they take, or don’t take, can have ripple effects on their own…
People living with dementia face complex legal concerns, and the actions that they take, or don’t take, can have ripple effects on their own…
Neuroscientist Kristen Willeumier, PhD, author of Biohack Your Brain, and neurologist Dr. Majid Fotuhi, author of Boost Your Brain, help us understand why we…
There are a lot of unanswered questions about Alzheimer’s, but one thing the Alzheimer’s community knows well is that getting older is the disease’s…
Even though the Alzheimer’s drug aducanumab has faced many twists and turns along its path to FDA approval, experts say that approval of Biogen’s…
Certain genes like ApoE that play an important role in the disease. ApoE’s genetic variant, known as ApoE4, is the strongest genetic risk factor…
Mary Lou Grace Robison only picked up art at the beginning of high school, but looking at her pieces, you’d think she was decades…
Receiving a dementia diagnosis is often overwhelming. For Jim Butler, the reality filled him with doubt and fear, especially during moments when he experienced…
Roughly 2.4 million Americans experience symptoms of dementia-related psychosis, ranging from visual and auditory hallucinations, to paranoid delusions and mistrust of loved ones. While…
For families including those with loved ones who have dementia, navigating the system of conservatorship can be daunting. In November 2020, a Los Angeles…
Concussions are a serious problem. With symptoms ranging from a day-or-two-long headache up to prohibitive dizziness and cognitive issues that could last for weeks,…
The initial results from Eli Lilly and Co’s Phase 2 clinical trial for experimental Alzheimer’s drug donanemab provide much needed hope for the Alzheimer’s…
“There are one too many similarities for this to be a coincidence,” says a recent Popular Mechanics review of new brain research. We’ve got…
As part of our BrainTalk series, Being Patient sat down in 2021 with Executive Director of ACADIA Pharmaceuticals Dr. Erin Foff and Chris Schwilk,…
Carolee Lee of WHAM! and Michelle M. Mielke at the Mayo Clinic examine the consequences of ignoring gender and biology in Alzheimer’s research —…
Despite more than a century of research since Alzheimer’s disease was first described in 1906, diagnosing Alzheimer’s remains extremely challenging for physicians. Researchers are…